A Phase III, Randomized, Open-Label, Comparative, Multi-Center Study to Assess the Safety and Efficacy of Prograf (Tacrolimus) and MR4 (Modified Release Tacrolimus) in de Novo Liver Transplant Recipients
Phase of Trial: Phase III
Latest Information Update: 30 Sep 2009
At a glance
- Drugs Tacrolimus (Primary)
- Indications Liver transplant rejection
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 30 Aug 2009 Results were presented at the 14th Congress of the European Society for Organ Transplantation.
- 12 Aug 2008 New trial record.